|
Ros-Bernal F., Hunot S., Herrero M.T., Parnadeau S., Corvol J.C., Lu L., Alvarez-Fischer D., Sauvage M.A.C.D., Saurini F., Coussieu C., Kinugawa K., Prigent A., Höglinger G., Hamon M., Tronche F., Hirsch E.C., Vyas S. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. 19 April 2011. 108:6632-6637. 10.1073/pnas.1017820108
AÑO: 2011; IF: 9.681
|
21467220
|
Barcia C., Ros C.M., Annese V., Gómez A., Ros-Bernal F., Aguado-Year C., Martínez-Paǵn M.E., De Pablos V., Fernandez-Villalba E., Herrero M.T. IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death and Disease. April 2011. 2. 10.1038/cddis.2011.17
AÑO: 2011; IF: 5.333
|
|
Zinger A, Barcia C, Herrero MT, Guillemin GJ. The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease. Parkinsons Dis. 2011;2011:716859. doi: 10.4061/2011/716859. Epub 2011 Jun 3. PubMed PMID: 21687761; PubMed Central PMCID: PMC3109408.
AÑO: 2011
|
|
Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT. Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Front Neurol. 2011 Dec 22;2:82. doi: 10.3389/fneur.2011.00082. eCollection 2011. PubMed PMID: 22203816; PubMed Central PMCID: PMC3244758.
AÑO: 2011
|
|
Herrero M.T., Pagonabarraga J., Linazasoro G. Neuroprotective role of dopamine agonists: Evidence from animal models and clinical studies. Neurologist. November 2011. 17:S54-S66. 10.1097/NRL.0b013e31823968fc
AÑO: 2011; IF: 1.261
|